IGM Biosciences, Inc.
Multimeric bispecific binding molecules specific for CD20 and CD3

Abstract:

This disclosure provides pentameric and hexameric CD20 binding molecules and methods of using such molecules to direct complement-mediated, T-cell-mediated, or both complement-mediated and T-cell-mediated killing of CD20-expressing cells.